Physician profile
Julia Tolin
NPI 1215652524
$3,406.88
in general payments reported to CMS, 2019-2025
10 companies · $3,020 in 2025
The $3,020 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $240 · 2024: $146 · 2025: $3,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781 · Travel and Lodging: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.65 |
| Travel and Lodging | $1,626.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,572.37 | 2025 | Ortholoc 2 Lapifuse, Pangea |
| Mid-Atlantic Surgical Systems, LLC | $511.95 | 2024-2025 | |
| Smith+Nephew, INC. | $295.16 | 2025 | Stravix, Grafix Pl |
| Bioventus LLC | $249.93 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $227.03 | 2023-2025 | Zynrelef |
| Innovation Technologies INC | $154.17 | 2025 | Irrisept |
| Convatec INC. | $132.03 | 2025 | |
| Kuros Biosciences USA, INC | $130.13 | 2025 | Magnetos |
| Inari Medical, INC. | $118.38 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Organogenesis INC. | $15.73 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Tolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.